Iranian Red Crescent Medical Journal

Published by: Kowsar

A “Stadium” Urticaria, Cold Urticaria Is Still a Mostly Unknown Disease, with a Wide Spectrum of Severity Degrees and Few Therapeutic Certainties: Is Omalizumab One of These? Reflections from a Clinical Case Report

Massimo De Martinis 1 , 2 , * , Maria Maddalena Sirufo 1 , 2 and Lia Ginaldi 1 , 2
Authors Information
1 Department of Life, Health and Environmental Sciences, University of L’Aquila, Italy
2 Allergy and Clinical Immunology Unit, AUSL 04 Teramo, Italy
Article information
  • Iranian Red Crescent Medical Journal: January 31, 2019, 21 (1); e84250
  • Published Online: January 16, 2019
  • Article Type: Case Report
  • Received: September 14, 2018
  • Revised: November 8, 2018
  • Accepted: November 11, 2018
  • DOI: 10.5812/ircmj.84250

To Cite: De Martinis M, Sirufo M M, Ginaldi L. A “Stadium” Urticaria, Cold Urticaria Is Still a Mostly Unknown Disease, with a Wide Spectrum of Severity Degrees and Few Therapeutic Certainties: Is Omalizumab One of These? Reflections from a Clinical Case Report, Iran Red Crescent Med J. 2019 ; 21(1):e84250. doi: 10.5812/ircmj.84250.

Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Introduction
2. Case Presentation
3. Discussion
  • 1. Metz M, Schutz A, Weller K, Gorczyza M, Zimmer S, Staubach P, et al. Omalizumab is effective in cold urticaria-results of a randomized placebo-controlled trial. J Allergy Clin Immunol. 2017;140(3):864-867 e5. doi: 10.1016/j.jaci.2017.01.043. [PubMed: 28389393].
  • 2. Wanderer AA, Grandel KE, Wasserman SI, Farr RS. Clinical characteristics of cold-induced systemic reactions in acquired cold urticaria syndromes: Recommendations for prevention of this complication and a proposal for a diagnostic classification of cold urticaria. J Allergy Clin Immunol. 1986;78(3 Pt 1):417-23. doi: 10.1016/0091-6749(86)90027-8. [PubMed: 3760401].
  • 3. Hochstadter EF, Ben-Shoshan M. Cold-induced urticaria: Challenges in diagnosis and management. BMJ Case Rep. 2013;2013. doi: 10.1136/bcr-2013-010441. [PubMed: 23839613]. [PubMed Central: PMC3736478].
  • 4. Dressler C, Werner RN, Eisert L, Zuberbier T, Nast A, Maurer M. Chronic inducible urticaria: A systematic review of treatment options. J Allergy Clin Immunol. 2018;141(5):1726-34. doi: 10.1016/j.jaci.2018.01.031. [PubMed: 29438771].
  • 5. Bodar EJ, Simon A, de Visser M, van der Meer JW. Complete remission of severe idiopathic cold urticaria on interleukin-1 receptor antagonist (anakinra). Neth J Med. 2009;67(9):302-5. [PubMed: 19841487].
  • 6. Gualdi G, Monari P, Rossi MT, Crotti S, Calzavara-Pinton PG. Successful treatment of systemic cold contact urticaria with etanercept in a patient with psoriasis. Br J Dermatol. 2012;166(6):1373-4. doi: 10.1111/j.1365-2133.2011.10797.x. [PubMed: 22212112].
  • 7. Maurer M, Altrichter S, Metz M, Zuberbier T, Church MK, Bergmann KC. Benefit from reslizumab treatment in a patient with chronic spontaneous urticaria and cold urticaria. J Eur Acad Dermatol Venereol. 2018;32(3):e112-3. doi: 10.1111/jdv.14594. [PubMed: 28924988].
  • 8. Maurer M, Metz M, Brehler R, Hillen U, Jakob T, Mahler V, et al. Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence. J Allergy Clin Immunol. 2018;141(2):638-49. doi: 10.1016/j.jaci.2017.06.032. [PubMed: 28751232].
  • 9. Sirufo MM, De Martinis M, Ginaldi L. Omalizumab an effective and safe alternative therapy in severe refractory atopic dermatitis: A case report. Medicine (Baltimore). 2018;97(24). e10897. doi: 10.1097/MD.0000000000010897. [PubMed: 29901580]. [PubMed Central: PMC6024249].
  • 10. Jain SV, Mullins RJ. Cold urticaria: A 20-year follow-up study. J Eur Acad Dermatol Venereol. 2016;30(12):2066-71. doi: 10.1111/jdv.13841. [PubMed: 27422852].
  • 11. Zuberbier T, Aberer W, Asero R, Abdul Latiff AH, Baker D, Ballmer-Weber B, et al. The EAACI/GA(2)LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy. 2018;73(7):1393-414. doi: 10.1111/all.13397. [PubMed: 29336054].
  • 12. Singleton R, Halverstam CP. Diagnosis and management of cold urticaria. Cutis. 2016;97(1):59-62. [PubMed: 26919357].
  • 13. Altrichter S, Peter HJ, Pisarevskaja D, Metz M, Martus P, Maurer M. IgE mediated autoallergy against thyroid peroxidase--a novel pathomechanism of chronic spontaneous urticaria? PLoS One. 2011;6(4). e14794. doi: 10.1371/journal.pone.0014794. [PubMed: 21532759]. [PubMed Central: PMC3075251].
  • 14. Schmetzer O, Lakin E, Topal FA, Preusse P, Freier D, Church MK, et al. IL-24 is a common and specific autoantigen of IgE in patients with chronic spontaneous urticaria. J Allergy Clin Immunol. 2018;142(3):876-82. doi: 10.1016/j.jaci.2017.10.035. [PubMed: 29208545].
  • 15. Raison-Peyron N, Philibert C, Bernard N, Du-Thanh A, Barbaud A, Bessis D. Cold contact urticaria following vaccination: Four cases. Acta Derm Venereol. 2016;96(6):852-3. doi: 10.2340/00015555-2358. [PubMed: 26832889].
  • 16. Kaplan AP, Gimenez-Arnau AM, Saini SS. Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria. Allergy. 2017;72(4):519-33. doi: 10.1111/all.13083. [PubMed: 27861988]. [PubMed Central: PMC5915348].
  • 17. Agbenyefia P, Shilliam LA, Stoicea N, Roth A, Moran KR. Perioperative management of a patient with cold urticaria. Front Med (Lausanne). 2017;4:222. doi: 10.3389/fmed.2017.00222. [PubMed: 29326933]. [PubMed Central: PMC5741599].
  • 18. Brodska P, Schmid-Grendelmeier P. Treatment of severe cold contact urticaria with omalizumab: Case reports. Case Rep Dermatol. 2012;4(3):275-80. doi: 10.1159/000346284. [PubMed: 23341807]. [PubMed Central: PMC3551415].
  • 19. Kitsioulis NA, Xepapadaki P, Kostoudi S, Manousakis E, Douladiris N, Papadopoulos NG. Omalizumab in pediatric cold contact urticaria: Warm blanket for a cold bath? Pediatr Allergy Immunol. 2016;27(7):752-5. doi: 10.1111/pai.12609. [PubMed: 27341491].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments